Nanomedicines Market Growth, Demand, status, and Trends during the Forecast period 2020-2027
Nanomedicines Market |
Nanotechnology is a broad word
encompassing nanoscale science, engineering, and technology that has enormous
economic and technical implications. One of the most notable areas of
nanotechnology study is healthcare. Nanomedicine is defined as the use of
molecular tools and understanding of the human body to diagnose, treat, and
prevent disease.
Nanomedicine is widely employed
in the treatment of chronic diseases such as cardiovascular disease, diabetes,
cancer, dementia, and others, where it helps drugs to be metabolised quickly in
the body. As a result, the rising prevalence of chronic illnesses is likely to
drive worldwide market growth. Despite incredible advances in medicine and
healthcare over the last few decades, with the introduction of breakthrough
products and therapies such as portable imaging devices, non-invasive surgical
tools, and advanced medical sensors, there is still a significant gap between
patient needs and available treatments.
Nanomedicine advances are attempting to fill this
need. The promise of nanomedicines in delivering pharmaceuticals at the
appropriate proportion and at the right pace would cater well to the demands of
complicated medical situations, greatly propelling the worldwide nanomedicines
market. The global growth in the prevalence of chronic illnesses will also have
a substantial impact on the Nanomedicines Market.
The global Nanomedicine
Market was valued at US$ 177.1 Bn in 2019 and is forecast to reach a
value of US$ 454.8 Bn by 2027 at a CAGR of 12.5% between 2020 and 2027.
Due to increased prevalence of
cancer and chronic illnesses worldwide, the global naomedicine industry is
likely to have substantial development prospects. Because of the increased
frequency of cancer throughout the world, nanomedicines play an essential role
in the oncology area. The enormous increase in the number of cancer patients
worldwide will retain oncology as one of the most attractive application
categories for nanomedicine during the forecast period. Factors like as
expanding public awareness of nanotechnology, rapidly increasing prevalence of
chronic diseases and malignancies, technical innovation, and rising government
investment in nanotechnology in various emerging nations are all driving the
nanomedicine industry.
Manufacturers are benefiting from
significant development prospects in the worldwide market as demand for
nanomedicines rises. Nanomedicine is a growing field of the healthcare business
that is gaining traction in medical and healthcare applications. There is a low
concentration of technology and nanomaterial vendors in the worldwide nanomedicine
industry. Manufacturers in the market rely on long-term contracts with
pre-negotiated terms and conditions for uninterrupted supply of raw materials
in domestic markets to mitigate the impact of the unavoidable demand-supply
imbalance caused by the low number of suppliers. The large sums of money
necessary to flourish in the technology- and research-driven sector of
nanomedicine have kept new entrants at bay. The nanomedicine market is
witnessing rapid growth due to increase in research and development activities
across the globe.
Top Companies in Nanomedicine Market include Abbott Laboratories,
CombiMatrix Corporation, Clene Nanomedicine, Inc., Cellics Therapeutics, Inc.,
Nanobiotix S.A, Celgene Corporation, GE Healthcare, NanoViricides, Inc.,
Johnson & Johnson, Mallinckrodt plc., Sirnaomics Inc., Precision
NanoSystems Inc., Merck & Company Inc., Nanosphere, Inc., Pfizer Inc., and
Sigma-Tau Pharmaceuticals Inc.
Comments
Post a Comment